Science Daily: Pharmacology News
APRIL 15, 2024
Over a ten-year period, biobank participants who met recommended levels of physical activity had a 23% lower risk of cardiovascular disease, and the protective effects were even more pronounced in individuals with depression.
BioPharma Drive: Drug Pricing
APRIL 15, 2024
Treatment appeared to result in functional and cognitive gains in people with the neurological disorder. Three participants experienced lower extremity weakness, however.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Science Daily: Pharmacology News
APRIL 15, 2024
Researchers have found that microplastics -- are having a significant impact on our digestive pathways, making their way from the gut and into the tissues of the kidney, liver and brain.
Drugs.com
APRIL 15, 2024
MONDAY, April 15, 2024 -- Doctors sometimes prescribe antibiotics to help treat a cough, but a new study shows the drugs won’t help reduce the severity or duration of coughing -- even if a bacterial infection is the culprit. Lower respiratory.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Science Daily: Pharmacology News
APRIL 15, 2024
Researchers have made a groundbreaking discovery regarding number sense in animals by confirming the existence of discrete number sense in rats, offering a crucial animal model for investigating the neural basis of numerical ability and disability in humans.
Crown Bioscience
APRIL 15, 2024
Organoid Xplore ™, developed by Crown Bioscience, is a large-scale organoid panel screen, executed every three months, in which clients can include their compounds for testing on organoid viability. It comprises a genetically characterized heterogeneous panel of tumor organoids and matching organoids derived from healthy epithelium from the same patients.
Drug Discovery Digest brings together the best content for drug research and development professionals from the widest variety of industry thought leaders.
Perficient: Drug Development
APRIL 15, 2024
Introduction: In the world of robotic process automation (RPA), Blue Prism stands out as a leading platform that empowers organizations to automate their business processes. While designing and developing automated solutions using Blue Prism is essential, debugging plays a crucial role in ensuring smooth operation and efficient execution. In this blog, we will explore some invaluable debugging techniques in Blue Prism that can help you identify and resolve issues, ultimately optimizing your auto
Science Daily: Pharmacology News
APRIL 15, 2024
The technology revolution and development of new renewable energy resources is driving demand for lithium to new heights, but it is not a common mineral. Scientists say they have found lithium in an unexpected place; fool's gold, or pyrite, deposits.
BioPharma Drive: Drug Pricing
APRIL 15, 2024
Because live cell and tissue products are extremely sensitive to contamination from microorganisms, viral particles or other airborne impurities, research and manufacturing involving these materials needs to be conducted in a cleanroom environment.
Science Daily: Pharmacology News
APRIL 15, 2024
Sports, beyond entertainment, foster community and belonging, benefiting both individuals and society. Despite its recognized positive effects, limited evidence exists on the link between watching sports and well-being. To address this gap, a team of researchers conducted a multi-method research and found that sports viewing activates brain reward circuits, leading to improved well-being.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
BioPharma Drive: Drug Pricing
APRIL 15, 2024
Learn about why access to robust biomarkers such as cfHPV-DNA is pivotal in determining eligibility, assessing treatment response and detecting recurrence early to improve patient outcomes.
Science Daily: Pharmacology News
APRIL 15, 2024
Researchers have discovered that an FDA-approved epilepsy drug can prevent or slow the growth of NF1-linked optic gliomas in mice, laying the groundwork for a clinical trial.
BioPharma Drive: Drug Pricing
APRIL 15, 2024
The results could give Roche’s Columvi an edge over a rival medicine from AbbVie and Genmab, while Regeneron awaits an approval of its own therapy.
Science Daily: Pharmacology News
APRIL 15, 2024
The mystery of how Pluto got a giant heart-shaped feature on its surface has finally been solved by an international team of astrophysicists. The team is the first to successfully reproduce the unusual shape with numerical simulations, attributing it to a giant and slow oblique-angle impact.
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
Drugs.com
APRIL 15, 2024
MONDAY, April 15, 2024 -- Americans are facing more shortages of the drugs they need for medical care than ever before, a national pharmacy database shows.The American Society of Health-System Pharmacists (ASHSP) and the University of Utah Drug.
Science Daily: Pharmacology News
APRIL 15, 2024
As sea levels rise, coastal groundwater is lifted closer to the ground surface while also becoming saltier and more corrosive. A recent study compiled research from experts worldwide showing that in cities where there are complex networks of buried and partially buried infrastructure, interaction with this shallower and saltier groundwater exacerbates corrosion and failure of critical systems such as sewer lines, roadways, and building foundations.
Drugs.com
APRIL 15, 2024
MONDAY, April 15, 2024 -- Volatile and toxic chemicals commonly stored in garages can increase the risk of amyotrophic lateral sclerosis (ALS).Gasoline or kerosene, gas-powered equipment and lawn care chemicals represented the top three risk.
Science Daily: Pharmacology News
APRIL 15, 2024
Sport junkie or couch potato? Always on time or often late? The animal kingdom, too, is home to a range of personalities, each with its own lifestyle. Biologists report on a surprising discovery: even simple marine polychaete worms shape their day-to-day lives on the basis of highly individual rhythms. This diversity is of interest not just for the future of species and populations in a changing environment, but also for medicine.
Drugs.com
APRIL 15, 2024
MONDAY, April 15, 2024 -- Dogs and cats can pass antibiotic-resistant bacteria to their owners, raising concerns that household pets could be contributing to the world’s antibiotics crisis, a new study says.Cases of these “superbugs” being.
Science Daily: Pharmacology News
APRIL 15, 2024
Researchers have shown that a transition to green wastewater-treatment approaches in the U.S. that leverages the potential of carbon-financing could save a staggering $15.6 billion and just under 30 million tons of CO2-equivalent emissions over 40 years.
Drugs.com
APRIL 15, 2024
MONDAY, April 15, 2024 -- Quiet preteens who feel they're a burden on others are more likely to have suicidal thoughts and behaviors, a new study reports.Criticism from parents or caregivers also increased the likelihood of suicidal thoughts and.
Science Daily: Pharmacology News
APRIL 15, 2024
Natural forest regeneration is hailed as a cost-effective way to restore biodiversity and sequester carbon. However, the fragmentation of tropical forests has restricted the movement of large birds limiting their capacity to disperse seeds and restore healthy forests.
Drugs.com
APRIL 15, 2024
MONDAY, April 15, 2024 -- Among U.S. women with migraine, a third say the attacks tend to coincide with their periods, a new survey finds. Migraines that occur during menstruation are often frequent and severe, but only about one in five.
Science Daily: Pharmacology News
APRIL 15, 2024
The study charts the family history of Arabica, the world's most popular coffee species, through Earth's heating and cooling periods over the last millennia.
Drugs.com
APRIL 15, 2024
MONDAY, April 15, 2024 -- While more than half of Americans say they would feel better with more sleep, only 42% say they are getting as much shut-eye as they need, a new poll finds.
NIOSH Science Blog: Drugs
APRIL 15, 2024
Work plays a significant role in workers’ mental health. This impact is so substantial that managers impact workers’ mental health more than doctors or therapists do, according to the Workforce Institute’s Mental Health at Work study. The U.S. Surgeon General even emphasizes the role of workplaces in shaping our mental and physical well-being, noting that the average full-time U.S. worker spends about half of their waking life at work.
Drugs.com
APRIL 15, 2024
MONDAY, April 15, 2024 -- You know exercise is great for your cardiovascular health, but new research suggests that your brain has a lot to do with it.It's all about physical activity's ability to lower stress levels within the brain, explained a.
BioPharma Drive: Drug Pricing
APRIL 15, 2024
Shares of the biotech dipped by double digits following disclosure the FDA had paused an early-stage study of Neumora’s muscarinic-targeting drug.
Cytel
APRIL 15, 2024
In the context of clinical trials, reducing the workload of the clinical team without compromising data quality is imperative for efficiency and cost-effectiveness. One key area that demands attention is the approach to Source Data Verification (SDV) and data review. Typically, the industry relies on 100% SDV, a resource-intensive quality assurance method that often leads to higher costs and staff turnover without necessarily improving data quality.
BioPharma Drive: Drug Pricing
APRIL 15, 2024
While corporate venture arms are commonplace among pharmaceutical companies, the new fund announced Monday is Regeneron’s first.
Olympian Clinical Research
APRIL 15, 2024
Alopecia areata is a condition that causes hair loss in patches on the scalp, face, or other parts of the body. Nearly 700,000 Americans have alopecia areata, which may occur at any age and affects both men and women equally. Currently, this condition has no cure, but treatments are available to help manage the symptoms. Recognizing the different types of alopecia areata, understanding the symptoms, and identifying triggers can help individuals better manage their condition.
Perficient: Drug Development
APRIL 15, 2024
In the fast-paced world of e-commerce, where growth and innovation are key, businesses need a platform that can scale with their growth. Enter Shopify Plus, the enterprise-level platform that helps high-volume merchants provide a seamless shopping experience for their customers without worrying about IT maintenance or infrastructure. In this series, we’ll explore what sets Shopify Plus apart, its key features and benefits, and why it’s the go-to choice for enterprise businesses world
Conversations in Drug Development Trends
APRIL 15, 2024
As the clinical research landscape continually evolves, the choice of a Contract Research Organization (CRO) partner can significantly impact the success of drug development programs. In fact, recent industry dynamics indicate a considerable shift in preference towards midsize CROs, driven by the need for more personalized, agile, and cost-effective partnerships.
The Premier Consulting Blog
APRIL 15, 2024
By William Salminen , Madelyn Huang, & Andrew Emanuel Without concrete guidelines, it can be confusing when determining what nonclinical studies are needed for a Pre-Investigational New Drug application (PIND) meeting. However, in our experience, the answer is this: it is critical that the nonclinical program provides sufficient data to allow the FDA to provide meaningful feedback on the proposed IND-enabling nonclinical program, but it should not be so extensive that time and money are was
Expert insights. Personalized for you.
136 
Let's personalize your content